Rghei, Amira D.
van Lieshout, Laura P.
Cao, Wenguang
He, Shihua
Tierney, Kevin
Lopes, Jordyn A.
Zielinska, Nicole
Baracuhy, Enzo M. http://orcid.org/0000-0001-8797-4825
Campbell, Elena S. B.
Minott, Jessica A.
Guilleman, Matthew M.
Hasson, Pamela C.
Thompson, Brad
Karimi, Khalil
Bridle, Byram W.
Susta, Leonardo
Qiu, Xiangguo
Banadyga, Logan http://orcid.org/0000-0001-8390-2648
Wootton, Sarah K. http://orcid.org/0000-0002-5985-2406
Article History
Received: 14 April 2022
Revised: 9 August 2022
Accepted: 19 August 2022
First Online: 1 September 2022
Competing interests
: LPvL and SKW are inventors on a US patent for the AAV6.2FF capsid. This patent (US20190216949) is licensed to Avamab Pharma Inc., where BT, LPvL and SKW are co-founders and BT serves as an executive. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
: Experiments involving animals were approved by the University of Guelph Animal Care Committee (AUP# 3827) or the Canadian Science Centre for Human and Animal Health Animal Care Committee (H-16-011) according to the guidelines set forth by the Canadian Council on Animal Care.